Our research group is actively engaged in several strategic partnerships aimed at advancing healthcare policy, education, and research.
Public Sector Partners
Ministry of Health (MOH), Jordan
Prof. Eman Hammad: Member of the Multi-Stakeholder Guidelines Development Working Group for Hypertension, Diabetes, and Cardiovascular Risk (2023–Present).
Role: Developing and updating national clinical guidelines using GRADE methodology to support primary care providers.
National Center for Human Resources Development (NCHRD)
Prof. Hammad: Advisory Committee Member for the National Study of Competency Education in the Pharmaceutical Industry (2023–Present).
Role: Developing competency standards and educational frameworks for the pharmaceutical workforce.
Health Technology Assessment (HTA) Steering Committee
Dr. Rimal Mousa: Member.
Role: Developing standardized criteria to evaluate medicines, devices, and healthcare programs for safety, cost, and impact.
Partners: MOH, Royal Medical Services, Jordan FDA, King Hussein Cancer Center.
Jordan Food and Drug Administration (JFDA)
Drug Pricing Committee (former members): Advocated for affordable medicines and refined regulatory processes.
Dr. Rimal: Proposed and developed a new checklist for evaluating economic feasibility studies (approved 2022).
Pharmacists Association Council
Research group consultancy (Nov–Dec 2024): Assessed Retirement and Disability Fund sustainability, identified challenges, and proposed strategic recommendations.
Public Health Institute (PHI), University of Jordan
Prof. Hammad and Dr. Rimal: Founding team members.
Contributions: Curriculum development, teaching, supervision, and mentoring in the Master of Health Economics and Policy.
Leadership roles: Dr. Rimal (Program Director), Prof. Hammad (Vice Director & Head, Health Economics Dept.).
Private Sector Partners
Hikma Pharmaceuticals
Dr. Rimal Mousa: Consultant in designing and conducting an economic evaluation using economic modeling.
Role: Supporting industry-driven health economics research.
International Partners
World Health Organization (WHO), USAID, and European Union Delegation
Prof. Hammad: National and international consultant.
Focus: Health financing, insurance costing, institutional assessments, and universal health coverage.
United Nations Population Fund (UNFPA) – Jordan
Dr. Rimal Mousa: Subject-Matter Expert in Health Economics for maternal and newborn healthcare improvement.
Contribution: Estimated financial needs, co-led workshops with the National Technical Committee for EmONC and HCAC, and developed a roadmap for approval by the Minister of Health.
Health Care Accreditation Council (HCAC)
Collaborations in maternal & newborn health quality improvement and healthcare strategy development.
Regional Centre for Disease Control and Prevention (RCDC)
Dr. Mousa: Expert consultant on economic evaluations and healthcare strategies.